Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7372 p510-511
22 October 2005

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Waste disposal
· The profession
· New pharmacy contract (2)
· Medicines use reviews
· Pharmacists in the media
· Registration examination
· North East London LPC (2)
· BPC (2)
· Packaging
· Primary care


Letters to the Editor

The profession

“Whistleblowing” will only work if changes are made at the top

From Mr H. A. Lockie, MRPharmS

Dame Janet Smith (PJ, 1 October, p420 PDF (75K)) contrasts the “whistleblowing” culture of the aviation industry with the “reluctance to report a colleague” in the medical professions. She observes that much can be learned from aviation and urges emulation.

As an active participant in both industries, I would very much agree. The aviation industry has an outstanding record of safety improvements over some 70 years and has developed its reporting mechanisms to a high level. But, as I am sure Dame Janet would be aware, “whistleblowing” will only work as part of a trusted “blame-free” culture where the rules are transparent and evidence-based.

To emulate the aviation industry it is necessary also to accept its explicitly stated and well understood premise that “risk is inherent in life and cannot be eliminated. It can however be controlled within acceptable limits” and its acceptance that highly trained professionals fail when a situation overwhelms them, rather than because they do not care.

Thus it is considered futile to blame the person at the controls. To do so will also result in cover-ups and thus nothing will be learned. A “blame-free” culture allows the true cause of errors to be detected and systems changed to prevent another professional being similarly overwhelmed in future. Part of this is “whistleblowing”, but much more is professionals “fessing up” at an early stage for which confidence in a “blame-free” response is a necessary precondition.

The aviation industry really does have this culture. There are usually no repercussions (other than embarrassment) for failure openly admitted, even when the consequences are quite serious, and the industry will defend its members against legal attack even when they are known to be wrong. The health professions do not currently have this culture: the “Shipman inquiry” was far from “blame-free”, for those unfortunate professionals deceived by Harold Shipman.

Then there is the transparency of the rules. The aviation industry requires them to be “evidence- based” because safety does not respond to political correctness, only to the rules of physics (and chemistry). Any aviation proposal that sought to cancel reciprocity for Australian and New Zealand pilots would have required a “notice of proposed rule change”, supported by hard data showing the harm that was being caused now by these pilots (deaths per 100 million passenger miles), the reduction in deaths that would arise from the change and the cost of the change. Only if this data were robust enough to repel challenges and the benefits statistically shown to outweigh the costs by a significant margin, could the change proceed. An opinion that the current situation might cause someone to object at some point in the future for political reasons would fail such a test, though it seems it was sufficient for pharmacy reciprocity to be cancelled. There is no place in a true safety system for assertions of benefit unsupported by hard evidence, just as there is no place in dispensing for assertions of purity of drugs.

It is most encouraging to see a person of Dame Janet’s stature proposing such a change. She is in just the position to encourage the administrators of pharmacy, and especially their disciplinary bodies, to undertake the profound change necessary for the health professions to emulate the aviation industry in its safety improvements.

Harvey Lockie
Auckland, New Zealand

Send your letter to The Editor

Previous Topic (Waste disposal)
Next Topic (New pharmacy contract)

Back to Top


©The Pharmaceutical Journal